Compared to hypofractionated radiotherapy, SBRT improves short-term but not long-term QoL in patients with inoperable stage I non-small cell lung cancer, new data show.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/sbrt-vs-standard-rt-which-offers-qol-edge-nsclc-2025a1000y62?src=rss
Author :
Publish date : 2025-12-05 20:22:00
Copyright for syndicated content belongs to the linked Source.
